Montair 5mg Chewable
Available Dosages
| SKU | 700 |
|---|---|
| Generic For | Singulair |
| Strength | 5mg |
| Active Ingredient | Montelukast Sodium |
| Pack Size | Qty | Price Per Pill or Unit | Price | Cart | |
|---|---|---|---|---|---|
| 30 Tablet/s | US$ 0.41 | US$ 12.30 | |||
|
|||||
| 60 Tablet/s | US$ 0.41 | US$ 24.60 | |||
|
|||||
| 90 Tablet/s | US$ 0.41 | US$ 36.89 | |||
|
|||||
Montair 5mg Chewable (Montelukast Sodium) – Affordable Singulair Alternative
Montair 5mg chewable pills are formulated to prevent asthma attacks in adults and pediatrics 12 months of age and older. It is extremely useful for those whose asthma is not under control by using regular inhaled corticosteroids and short-acting beta agonist relievers. The medicine is used in addition to these drugs. The main ingredient of the medicine is Montelukast sodium, which is a leukotriene antagonist. This pharmaceutical drug is used worldwide for the treatment of various seasonal allergies and especially for relieving signs of asthma.
What is Montair chewable used for?
Montair chewable tablets are for the prevention and chronic treatment of asthma. It is also prescribed to manage seasonal allergic rhinitis. Furthermore. It is useful in preventing exercise-induced bronchoconstriction in patients six years and older.
How does Montair chewable work?
Being a leukotriene against, the active ingredient of the medicine works by antagonizing the effects of leukotrienes, which mediate airway edema, smooth muscle constriction, altered cellular activity. This results in decreased frequency and severity of acute asthma attack.
What does Montair chewable contain?
The tablets contain Montelukast sodium as the main ingredient. Montelukast sodium is a selective and orally active leukotriene receptor agonist, which is helpful in preventing seasonal, perennial allergic rhinitis.
What medications interact with Montair chewable?
Certain other medications can interact with Montair chewable tablets and cause health issues. So, it is important to consult your physician before taking any medication. Especially, tell your physician about the following drugs:
- Cimetidine
- Ivacaftor
- Heparin
- Gemfibrozil
- Esomeprazole
- Antifungal drugs like itraconazole
- Antidepressant medications like rifabutin, rifampin, rifapentine
- St. John’s Wort
- Prostate disorder drugs
- High blood pressure medications
- HIV drugs like darunavir, atazanavir, ritonavir, etc.
When should Montair chewable not be used?
The chewable tablets are not suitable for patients who are hypersensitive to Montelukast sodium or other components of the medication.
Exercise caution in the following situations:-
- Acute attacks of asthma
- Hepatic insufficiency
- Phenylketonuria
- Reduction of corticosteroid therapy
- Pregnancy
- Lactation
- Pediatrics
What are the side effects of Montair chewable?
- Gastrointestinal issues- diarrhea, nausea, dyspepsia, abdominal pain, increased liver enzymes
- Neurological disorders- tremor
- EENT disorders- otitis, nosebleed, sinusitis
- Central nervous system disorders- Anxiety, fatigue, hallucinations, aggressions, suicidal thoughts, dream abnormalities, insomnia, weakness, restlessness, disorientation, anxiety, insomnia, irritability, headache
- Dermatological issues- toxic epidermal necrolysis, Stevens-Johnson syndrome, rash
- Respiratory disorders- rhinorrhea, cough
- Miscellaneous issues- fever, eosinophilic conditions
How should Montair chewable be used?
The medicine should be taken once daily, in the evening. Take the tablet one hour or two hours after a meal. The tablet is meant to be chewed and sucked, avoid swallowing it.
Patients are instructed to take medicine on a regular basis. Keep taking it when your symptoms are under control. Do not discontinue the treatment unless instructed to you by your physician.
How long should you use Montair chewable?
Take the chewable tablets as long as the physician prescribes you to do. Do not discontinue the treatment without discussing with your physician.
Missed dose of Montair chewable
If you forget to take the dose of Montair chewable tablets, skip that dose and take the next dose on the recommended period if it’s too late, but if is less than the 12 hours of the missed dose then go and take it. Avoid taking two doses at the same time to recognize the missed one.
How should Montair chewable be stored?
Store it at controlled room temperature. Protect it from direct light and moisture. Always store in original package. Do not freeze the medicine.
What is Montair 5mg Chewable Tablet used for?
Montair 5mg Chewable Tablet contains montelukast Sodiumium 5mg — the school-age children's formulation for ages 6–14 years. Indications: prophylaxis and chronic treatment of asthma in children 6–14 years; seasonal allergic rhinitis in children 2 years and older (though 5mg is specifically for 6–14 year-olds for this indication); and perennial allergic rhinitis in children 6–14 years. Montelukast 5mg prevents leukotriene-mediated airway inflammation and mucus secretion, reducing asthma exacerbation frequency and allergic rhinitis symptoms. The 5mg dose provides intermediate exposure between the 4mg paediatric and 10mg adult formulations — appropriately calibrated for school-age children's developing pharmacokinetic profile. Evening once-daily dosing reduces overnight airway inflammation when school-age children with asthma typically experience most symptoms.
How should Montair 5mg Chewable be given for asthma in school-age children?
Give Montair 5mg Chewable Tablet once daily in the evening. The tablet should be chewed (not swallowed whole) — school-age children can typically chew tablets effectively. Can be taken with or without food. Evening dosing is preferred for asthma. Give consistently every evening — even on days when the child is symptom-free. For exercise-induced bronchoconstriction: give at least 2 hours before exercise; if the child is already taking daily montelukast, no additional dose is given for exercise (maximum once daily). For allergic rhinitis alone (without asthma): same once-daily evening dosing for 6–14 year-olds. Parents should review medication administration with the school nurse for any scheduled doses — montelukast is once-daily in the evening, so school administration is usually not needed.
What are the neuropsychiatric concerns for school-age children on Montair 5mg?
The FDA neuropsychiatric Boxed Warning applies to all montelukast formulations including the 5mg chewable for school-age children. School-age children (6–14 years) may experience and express neuropsychiatric effects more clearly than younger children: sleep problems (difficulty falling asleep, nightmares, night terrors); daytime anxiety or worry; mood changes (sadness, withdrawal, loss of interest); aggression or unusual agitation; depression. School-age children can often verbalise mood changes — ask specifically at each review. Teachers and parents should monitor for unexplained academic performance decline, social withdrawal, or behavioural changes that coincide with montelukast initiation. If neuropsychiatric symptoms occur: stop montelukast immediately and contact the prescribing doctor. The risk appears greatest in the first weeks of treatment but can occur at any time.
What drug interactions apply to Montair 5mg Chewable?
Identical pharmacokinetic interaction profile to the adult and 4mg formulations — CYP3A4 and CYP2C8 pathways. In school-age children: phenobarbitone, phenytoin, carbamazepine (common paediatric antiepileptics) reduce montelukast levels via CYP3A4 induction — reduced asthma/rhinitis control may result; dose adjustment or alternative controller therapy may be needed. Rifampicin (used for TB in children): markedly reduces montelukast exposure. Inhaled corticosteroids (budesonide, fluticasone): no pharmacokinetic interaction — safe and commonly combined in step-up asthma therapy. Antihistamines (cetirizine, loratadine, desloratadine): no pharmacokinetic interaction — frequently combined for rhinitis + asthma in school-age children.
Is Montair 5mg Chewable equivalent to Singulair 5mg Chewable?
Yes. Montair 5mg Chewable and branded Singulair 5mg Chewable both contain montelukast Sodiumium 5mg in equivalent chewable tablet formulations for school-age children. Montair is the generic alternative providing the same paediatric leukotriene receptor antagonist therapy at significantly lower cost. PremiumRxDrugs.com stocks authentic manufacturer-sourced Montair 5mg Chewable verified for quality and bioequivalence.
Can I order Montair 5mg Chewable from PremiumRxDrugs for international delivery?
Yes. PremiumRxDrugs.com ships Montair 5mg Chewable to the USA, UK, Australia, and many other countries. Our genuine manufacturer-verified paediatric montelukast tablets, competitive pricing, and free worldwide shipping on qualifying orders make us a reliable international pharmacy for school-age asthma management.
What side effects does Montair 5mg Chewable cause in school-age children?
Common: headache; abdominal pain; nausea; diarrhoea; pharyngitis. Neuropsychiatric (Boxed Warning — monitor carefully): anxiety, agitation, aggression, sleep disturbances (nightmares, insomnia), depressive mood, suicidal thinking (rare — but specifically listed; any such thoughts require immediate medical attention). Respiratory infections: common coincidentally in the asthmatic school-age population — not caused by montelukast. Rare: elevated liver enzymes; hypersensitivity reactions (rash, angioedema); Churg-Strauss vasculitis (extremely rare in children). If the child develops any new mood, behavioural, or sleep changes after starting Montair 5mg: stop immediately and contact the doctor. Do not continue if neuropsychiatric symptoms appear — the medication should not be resumed without specialist review.
How is Montair 5mg Chewable used in combination with inhaled corticosteroids for step-up asthma therapy?
GINA guidelines for school-age children with uncontrolled asthma on low-dose ICS: add montelukast 5mg as step-up therapy before increasing ICS dose. The combination (ICS + montelukast) provides: ICS addresses eosinophilic airway inflammation; montelukast additionally blocks leukotriene-driven bronchoconstriction and mucus secretion — complementary mechanisms. Clinical benefit: significant reduction in exacerbation frequency; improved daytime symptoms; reduced rescue bronchodilator use. For school-age children with both asthma and allergic rhinitis: the combination of an inhaled corticosteroid (for asthma) + montelukast (addressing both asthma and rhinitis) + intranasal steroid (for rhinitis) provides comprehensive co-morbidity management. The simpler regimen of montelukast addressing both conditions simultaneously is an advantage in treatment adherence.
Can Montair 5mg Chewable be taken during a respiratory infection that triggers asthma?
Yes — continue Montair 5mg during respiratory viral infections that trigger asthma exacerbations. This is an important principle: montelukast is a daily controller medication that should never be stopped during an illness. Continuing montelukast during viral infections is particularly beneficial: leukotrienes are major inflammatory mediators in virus-triggered asthma exacerbations; montelukast blocking leukotriene receptors provides specific protection against the dominant inflammatory pathway in viral-induced wheezing in school-age children. During an acute exacerbation: maintain montelukast; increase reliever inhaler (salbutamol) as needed; follow the child's written asthma action plan. If exacerbations are not controlled with reliever + controller therapy: oral corticosteroid course may be needed — consult the child's GP or paediatrician.
How should Montair 5mg Chewable be stored?
Store Montair 5mg Chewable at room temperature (15–30°C) away from direct sunlight, moisture, and heat. Keep in the original foil blister until just before administration. Keep out of reach of children — despite being a children's medication, unsupervised access to multiple tablets is a safety concern. Store in a consistent, accessible location that parents remember — medication adherence for chronic conditions depends on habit formation around storage and administration. Check expiry date regularly. Do not store in the bathroom (humidity can degrade the tablet). Dispose of expired tablets by returning to a pharmacy. If travelling: keep medication in carry-on luggage to prevent temperature extremes in aircraft cargo holds.
How does Montair 5mg help children with both asthma and allergic rhinitis?
Montelukast 5mg uniquely treats both asthma and allergic rhinitis simultaneously — an important advantage for the 60-80% of school-age children with both conditions (the unified airway concept). A single evening tablet replaces the need for separate asthma and rhinitis controllers in many children. Clinical benefit for combined disease: improved asthma control scores; reduced nasal congestion and rhinorrhoea; reduced nighttime symptoms from both conditions; fewer missed school days. For children requiring both conditions treated: montelukast 5mg as once-daily controller combined with a topical nasal steroid (if rhinitis is severe) provides comprehensive unified airway management. This simplicity improves adherence vs. multiple separate inhaled and nasal formulations in the school-age group.
Login
Sign Up
Login
Sign Up